Please sign in to follow a disease.
CVRx, Inc.
Clinical trials sponsored by CVRx, Inc., explained in plain language.
A medical device company developing neuromodulation therapies for cardiovascular diseases.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- A neck implant aims to quiet Hard-to-Treat high blood pressure Results expected Jul 2027 (estimated)
- Nerve-stimulating implant tested for easing heart failure symptoms Results expected Jul 2027 (estimated)
-
Could a neck implant be the lifeline heart failure patients need?
Disease control Recruiting nowThis study tests a device called Barostim that stimulates nerves in the neck to help the heart work better. It involves 2,500 adults with moderate heart failure who still have symptoms despite standard treatments. The goal is to see if the device reduces deaths and hospital stays…
Sponsor: CVRx, Inc. • Aim: Disease control
Last updated Sep 21, 2026 16:00 UTC
-
A neck implant aims to quiet Hard-to-Treat high blood pressure
Disease control Recruiting nowResearchers are following 500 people with resistant hypertension who have received the Barostim Neo device, an implant that stimulates blood pressure sensors in the neck. The registry tracks blood pressure readings, changes in blood pressure medications, and health care visits ov…
Sponsor: CVRx, Inc. • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Nerve-stimulating implant tested for easing heart failure symptoms
Symptom relief Recruiting nowResearchers are tracking 500 people with heart failure and reduced ejection fraction who received the Barostim Neo device, which stimulates nerves near the carotid artery to calm the body's stress response. The registry follows participants for six months to see whether the devic…
Sponsor: CVRx, Inc. • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC